Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays

Several automated high-throughput immunoassays for detecting anti-SARS-CoV-2 antibodies by a semi-quantitative approach have been commercialized. In this study, we describe the timeline of the antibody response in patients with RT-PCR-confirmed COVID-19. A total of 292 sequential serum samples from...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Katsumi, Kitagawa, Yutaro, Matsuoka, Masaru, Imai, Kazuo, Orihara, Yuta, Kawamura, Rieko, Sakai, Jun, Ishibashi, Noriomi, Tarumoto, Norihito, Takeuchi, Shinichi, Maesaki, Shigefumi, Maeda, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954771/
https://www.ncbi.nlm.nih.gov/pubmed/33744623
http://dx.doi.org/10.1016/j.diagmicrobio.2021.115370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954771/
https://www.ncbi.nlm.nih.gov/pubmed/33744623
http://dx.doi.org/10.1016/j.diagmicrobio.2021.115370

Ejemplares similares